Abstract: The invention provides compounds of formula (I): wherein: R1-R4 and A have any of the values defined in the specification, and their pharmaceutically acceptable salts, are useful for inhibiting ?-lactamase enzymes, for enhancing the activity of ?-lactam antibiotics, and for treating ?-lactam resistant bacterial infections in a mammal. The invention also provides pharmaceutical compositions, processes for preparing compounds of formula (I), and intermediates useful for the synthesis of compounds of formula (I).
Type:
Grant
Filed:
May 10, 2005
Date of Patent:
February 10, 2009
Assignee:
Southern Methodist University Foundation for Research
Abstract: Compounds of formula I: wherein R1, R2, R3, R4 and n have any of the values defined in the specification, and their pharmaceutically acceptable salts, are useful for inhibiting ?-lactamase enzymes, for enhancing the activity of ?-lactam antibiotics, and for treating ?-lactam resistant bacterial infections in a mammal. The invention also provides pharmaceutical compositions, processes for preparing compounds of formula I, and novel intermediates useful for the synthesis of compounds of formula I.
Type:
Grant
Filed:
May 27, 2004
Date of Patent:
October 24, 2006
Assignee:
Southern Methodist University Foundation for Research
Inventors:
John D. Buynak, Akireddy Srinivasa Rao, Venkata Ramana Doppalapudi